Login

Relationship-first fund investing in early stage startups|Joachim Laqueur,General Partner,Acrobator Ventures 00:10:00

Share On Facebook Share On Twitter

General Partner at Acrobator Ventures

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Per Lekander: Visionary Fund Manager at Lansdowne Partners
00:00:00
Allergy Therapeutics to sniff out more M&A deals - Manuel Llobert, CEO, Allergy Therapeutics
00:10:00
Meet Kendall King, CFP®, AEP®: Founder and Leader at Castlepoint Wealth Advisors
00:10:00
Jeff Bezos In 1999 On Amazon's Plans Before The Dotcom Crash
00:10:00
Investing for retirement made easier | Ron Peyton,CEO and executive chairman, CIT Callan International Equity Fund
00:10:00
IDM Mining's Red Mountain Gold Project: High-Grade Gold Production and Exploration in Northwestern BC - Insights from the One-to-One Mining Investment Conference in New York
00:10:00
DEUTZ CMD 2023: CEO Sebastian Schulte's Strategy Update | Dr. Sebastian C. Schulte - CEO of DEUTZ AG
00:10:00
Momentum Stocks, Employment Reports, and Kitties: A Unique Take on Investing | Jim Evans, Co-Founder , TTG Financial Inc.
00:10:00
Susan Senecal, President & COO of A&W Canada, on A&W’s Corporate Responsibility in January | Susan Senecal, President , A&W Revenue Royalties Income Fund.
00:10:00
David Lee on IV Solutions' Evolution from Video Surveillance to Advanced AI and IoT Applications
00:10:00
investing in real estate finance insurance and home services|Constance Freedman,Managing Partner,Moderne Ventures
00:10:00
Meet Jason Gunkel: Syverson Strege Team | Jason Gunkel, Chief Investment Officer, Financial Planner of Syverson Strege

© 2017 - Neuhu+